<DOC>
	<DOC>NCT02586259</DOC>
	<brief_summary>The purpose of this study is to evaluate Cortiment® with regard to its use by clinicians in routine clinical practice and its effectiveness and tolerability in a real-life setting.</brief_summary>
	<brief_title>Effectiveness of Cortiment® in Patients With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Men and women aged ≥ 18 years Outpatients Patients who have been prescribed Cortiment® for the treatment of mild to moderate active ulcerative colitis Patients who have received adequate information regarding this noninterventional study and are able to understand and voluntarily sign the Informed Consent Patients with severe active / fulminant ulcerative colitis Patients treated with antibiotics or corticosteroids for the current flare History of total / subtotal colectomy Hypersensitivity to the active substance, lecithin (derived soya oil, peanut oil) or to any of the excipients Patients enrolled and involved in an interventional study Patients whom investigators consider inappropriate to participate in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>